Cannabis use as harm reduction in the Eastern Caribbean
| Autor: | Marcus Day |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Drug
medicine.medical_specialty Harm reduction biology media_common.quotation_subject Poly drug use 030508 substance abuse Medicine (miscellaneous) Cannabis use biology.organism_classification 03 medical and health sciences Psychiatry and Mental health Clinical Psychology 0302 clinical medicine medicine Cannabis 0305 other medical science Crack cocaine Psychology Psychiatry 030217 neurology & neurosurgery media_common |
| Zdroj: | Drugs and Alcohol Today. 18:172-177 |
| ISSN: | 1745-9265 |
| Popis: | Purpose The purpose of this paper is to present evidence of the therapeutic value of cannabis as a harm reduction intervention with people who smoke crack cocaine. Design/methodology/approach A desk study of published peer-reviewed material supporting the use of cannabis as therapeutic in mitigating some of the harms associated with crack cocaine smoking. Findings The use of cannabis as a harm reduction strategy for crack cocaine use has been commented on in the scientific literature since the 1980s. The officially scheduling of cannabis as having no medicinal value hampered further study despite the reporting of positive findings and numerous calls for more research. Practical implications There are currently no approved pharmaceutical substitutions for crack cocaine. Cannabis has shown itself effective in mitigating harms for 30–40 per cent of people. Cannabis is inexpensive and readily available and should be allowed for those people who want to use it. Originality/value Poly drug use is often framed in a negative context. In this paper, the author shows that with cannabis and crack, the poly drug use is actually a valid harm reduction strategy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|